Prognostic markers in renal cell carcinoma: A focus on the ‘mammalian target of rapamycin’ pathway
Authors:
Open Access
- 9 April 2012
- journal article
- review article
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 10 (2) , 110-117
Abstract
Objectives: Increased knowledge about the molecular pathways involved in tumorigenesis has led to the discovery of new prognostic molecular markers and development of novel targeted therapies for renal cell carcinoma (RCC). In this review we describe the prognostic markers of RCC and highlight the areas of recent discovery with a focus on the mammalian target of rapamycin (mTOR) pathway. Methods: We reviewed previous reports, using PubMed with the search terms ‘renal cell carcinoma’, ‘molecular markers’, ‘prognosis’, ‘outcomes’ and ‘mammalian target of rapamycin pathway’ published in the last two decades. We created a library of 100 references and focused on presenting the recent advances in the field. Results: Growing evidence suggests that mTOR deregulation is associated with many types of human cancer, including RCC. Consequently, temsirolimus and everolimus, which target mTOR, are approved for treating advanced RCC. There is a demand to integrate clinical, pathological and molecular markers into accurate prognostic models to provide patients with the most personalised cancer care possible. Conclusions: The mTOR pathway is highly implicated in RCC tumorigenesis and progression, and its constituents might represent a promising prognostic tool and target for treating RCC. Combining newly discovered molecular markers with classic clinicopathological prognostics might potentially improve the management of RCC.Keywords
This publication has 67 references indexed in Scilit:
- Breaking through a Plateau in Renal Cell Carcinoma Therapeutics: Development and Incorporation of BiomarkersMolecular Cancer Therapeutics, 2010
- Predictive biomarker discovery through the parallel integration of clinical trial and functional genomics datasetsGenome Medicine, 2010
- Sunitinib impairs the proliferation and function of human peripheral T cell and prevents T-cell-mediated immune response in miceClinical Immunology, 2009
- Development and evaluation of BioScoreCancer, 2009
- Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinomaInternational Journal of Cancer, 2008
- Gene Expression Profiling Predicts Survival in Conventional Renal Cell CarcinomaPLOS Medicine, 2005
- p21 WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivoJournal of Cancer Research and Clinical Oncology, 2003
- mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth MachineryCell, 2002
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999
- The activation of phosphatidylinositol 3-kinase by RasCurrent Biology, 1994